StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie GAAP Operating Margin Ratio by Quarter

GAAP Operating Margin Ratio (%) (%)

AbbVie GAAP Operating Margin Ratio: 37.9% in Q2 2026, up 6.2 pts from a year earlier.

Latest, Q2 2026
37.9%
Period ended Jun 30, 2026
Change on a year earlier
+6.2 pts
31.7% in Q2 2025
History
31 quarters
Since Q4 2017
Sources
31
Documents cited below

Where the Q2 2026 figure comes from

“On a GAAP basis, the operating margin ratio in the second quarter was 37.9 percent. The adjusted operating margin ratio was 48.3 percent”

Source: Form 8-K (abbv-20260630xexhibit991.htm, filed 2026-07-31) ↗

Reported in Form 8-K Earnings Release.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGAAP Operating Margin Ratio (%) (%)Year on yearSource
Q2 2026Jun 30, 202637.9%+6.2 ptsForm 8-K (abbv-20260630xexhibit991.htm, filed 2026-07-31) ↗
Q1 2026Mar 31, 202626.6%-1.4 ptsForm 8-K (abbv-20260331xexhibit991.htm, filed 2026-04-29) ↗
Q4 2025Dec 31, 202527.3%–Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗
Q3 2025Sep 30, 202512.1%-14.4 ptsForm 8-K (abbv-20250930xexhibit991.htm, filed 2025-10-31) ↗
Q2 2025Jun 30, 202531.7%+4.1 ptsForm 8-K (abbv-20250630xexhibit991.htm, filed 2025-07-31) ↗
Q1 2025Mar 31, 202528.0%+5.3 ptsForm 8-K (abbv-20250331xexhibit991.htm, filed 2025-04-25) ↗
Q3 2024Sep 30, 202426.5%+10.1 ptsForm 8-K (abbv-20240930xexhibit991.htm, filed 2024-10-30) ↗
Q2 2024Jun 30, 202427.6%-4.9 ptsForm 8-K (abbv-20240630xexhibit991.htm, filed 2024-07-25) ↗
Q1 2024Mar 31, 202422.7%+0.1 ptsForm 8-K (abbv-20240331xexhibit991.htm, filed 2024-04-26) ↗
Q4 2023Dec 31, 202322.3%-14.1 ptsForm 8-K (abbv-20231231xexhibit991.htm, filed 2024-02-02) ↗
Q3 2023Sep 30, 202316.4%-14.7 ptsForm 8-K (abbv-20230930xexhibit991.htm, filed 2023-10-27) ↗
Q2 2023Jun 30, 202332.5%+9.9 ptsForm 8-K (abbv-20230630xexhibit991.htm, filed 2023-07-27) ↗
Q1 2023Mar 31, 202322.6%-12.2 ptsForm 8-K (abbv-20230331xexhibit991.htm, filed 2023-04-27) ↗
Q4 2022Dec 31, 202236.4%+2.3 ptsForm 8-K (abbv-20221231xexhibit991.htm, filed 2023-02-09) ↗
Q3 2022Sep 30, 202231.1%+1.1 ptsForm 8-K (abbv-20220930xexhibit991.htm, filed 2022-10-28) ↗
Q2 2022Jun 30, 202222.6%-9.2 ptsForm 8-K (abbv-20220630xexhibit991.htm, filed 2022-07-29) ↗

Cite this data

StockData. (2026). AbbVie GAAP Operating Margin Ratio (%), quarterly Q4 2017–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/margin-gaap-om

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.